Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...

Just a few weeks after Abbott presented the successful results of a trial of its Aveir DR dual-chamber leadless pacemaker system—data that it said had been promptly submitted for regulatory review—the ...

Nearly a year after garnering an FDA nod, Abbott’s wireless, dual-chamber pacemaker system is crossing the pond with a CE Mark approval in Europe. The Aveir DR includes a pair of separate devices, ...

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- A revolutionary advancement in cardiac care is changing what’s possible for people living with slow or abnormal heart rhythms. On October 13th, Abbott ...

Abbott ABT recently received FDA approval for its pioneering AVEIR dual chamber (DR) leadless pacemaker system. The approval comes following the recent late-breaking clinical trial data showing that ...

Abbott (NYSE:ABT) said it has received FDA approval for its dual-chamber leadless pacemaker system Aveir DR for the treatment of slow or abnormal heart rhythms. The medical device maker said the ...

Abbott (ABT)'s breakthrough technology enables the world's first beat-to-beat, wireless communication and synchronization between two leadless pacemakers, which are smaller than a AAA battery Leadless ...

(RTTNews) - Abbott Laboratories (ABT) a biopharmaceutical major, announced on Wednesday that it has received FDA approval for its dual chamber (DR) leadless pacemaker system dubbed AVEIR. As per the ...

The FDA has approved Abbott Laboratories' ABT AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system to treat abnormal or slow heart rhythms. Through ...

A Bakersfield hospital Monday became the first in Kern County to successfully implant the AVEIR DR, the world's first dual-chamber leadless pacemaker system from Abbott that treats people with ...

PORTLAND, Ore (KOIN) – On behalf of our sponsors at Abbott, we’re learning about how a medical breakthrough is transforming the way we treat abnormal heart rhythms and one Boston mother’s story shows ...

Leadless cardiac electrophysiology devices have been around for a while now, but Abbott Laboratories of Abbott Park, Ill., has managed to beat the competition in the market for dual chamber pacing via ...